<DOC>
	<DOC>NCT01289938</DOC>
	<brief_summary>Pharmacokinetic of Metoclopramide (MCP) in correlation to polymorphisms of CYP2D6 and Dopamine-D2-Receptor. Pharmacokinetic of Diphenhydramine (DPH) in correlation to polymorphisms of CYP2D6</brief_summary>
	<brief_title>Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine</brief_title>
	<detailed_description />
	<mesh_term>Metabolism, Inborn Errors</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>BMI 20 27kg/m2 Caucasians Healthy volunteers Pregnancy/lactation period Drug allergy Acute and chronic diseases Taking medication Abuse of drugs, alcohol etc. Smoker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>pharmacokinetic</keyword>
	<keyword>pharmacogenetic</keyword>
	<keyword>Metoclopramide</keyword>
	<keyword>Diphenhydramine</keyword>
	<keyword>CYP2D6 polymorphisms</keyword>
</DOC>